Andrew Brooks

Andrew Ira Brooks (February 10, 1969January 23, 2021) was an American immunologist, academic, and businessman. He was an associate research professor at Rutgers University and the developer of the first FDA-approved rapid saliva test for COVID-19 diagnosis. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Andrew Brooks', query time: 0.03s Refine Results
  1. 1
    Aberrant Development of Thymocytesin Mice Lacking Laminin-2

    Aberrant Development of Thymocytesin Mice Lacking Laminin-2 by William J. Magner, Andrew C. Chang, Jennie Owens, M-J. P. Hong, Andrew Brooks, John E. Coligan

    Published 2000-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR

    Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR by Pui Yeng Lam, Natacha Omer, Josh K. M. Wong, Cui Tu, Louisa Alim, Gustavo R. Rossi, Maria Victorova, Hannah Tompkins, Cheng‐Yu Lin, Ahmed M. Mehdi, Amos Choo, Melissa R. Elliott, Elaina Coleborn, Jane Sun, Timothy Mercer, Orazio Vittorio, Lachlan J. Dobson, Alexander D. McLellan, Andrew Brooks, Zewen Kelvin Tuong, Seth W. Cheetham, Wayne Nicholls, Fernando Souza‐Fonseca‐Guimaraes

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: